All Stories

  1. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia

    Article • Cancer Biomarkers, October 2020, IOS Press

    Jingdong Zhou

  2. SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia

    Article • OncoTargets and Therapy, June 2019, Dove Medical Press

    jun qian, Jingdong Zhou

  3. Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia

    Article • OncoTargets and Therapy, May 2019, Dove Medical Press

    jun qian, Jingdong Zhou

  4. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia

    Article • Journal of Cellular Physiology, October 2018, Wiley

    jun qian, Jingdong Zhou

  5. Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia

    Article • Cancer Management and Research, October 2018, Dove Medical Press

    jun qian, Jingdong Zhou

  6. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia

    Article • Journal of Cellular Physiology, August 2018, Wiley

    jun qian, Jingdong Zhou

  7. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia

    Article • Journal of Cellular Physiology, February 2018, Wiley

    jun qian, Jingdong Zhou

  8. Overexpression of miR-216b : Prognostic and predictive value in acute myeloid leukemia

    Article • Journal of Cellular Physiology, September 2017, Wiley

    jun qian, Jingdong Zhou

  9. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia

    Article • Journal of Cellular Physiology, August 2017, Wiley

    jun qian, Jingdong Zhou

  10. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies

    Article • Journal of Cellular and Molecular Medicine, April 2017, Wiley

    jun qian, Jingdong Zhou